RE: Future possibilities26 Nov 2021 12:29
Last night CK confirmed that the 2M test capacity per week was 66% government equipment, and 33% ODX own capacity which means ODX have 330K per week currently for Health & Nutrition and Global Health divisions. Lets look at slide 17 for 6-months where they made £1.56M - It is clear that covid subcontracting for surescreen and pharmact make up 55% of this profit, but we dont know how many test contribute to the £863K - lets say its 0.50 per test so they may (optimistically) manufactured 2Million covid tests to round it up a bit. This isn't many, and therefore the numbers on this Financial slide look really poor. Really poor.
Going forwards, it is all about whether investors believe that the Global Health profitabilty can increase. I'm no longer sure of this, because it really feels like picking up scraps from Surescreen, Origene, and Pharmact to me.
The Health and Nutrition side of the business does look better, but that's not the reason the PIs piled in, is it?